Ignite Creation Date:
2025-12-25 @ 12:01 AM
Ignite Modification Date:
2025-12-25 @ 9:59 PM
Study NCT ID:
NCT01198158
Status:
TERMINATED
Last Update Posted:
2019-03-06
First Post:
2010-09-08
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-09-15
Start Date Type:
ACTUAL
Primary Completion Date:
2017-12-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-12-16
Completion Date Type:
ACTUAL
First Submit Date:
2010-09-08
First Submit QC Date:
None
Study First Post Date:
2010-09-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-02-06
Results First Submit QC Date:
None
Results First Post Date:
2019-03-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-03-05
Last Update Post Date:
2019-03-06
Last Update Post Date Type:
ACTUAL